• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imatron revenues soar 147%

Article

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June). Imatron recorded

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June).

Imatron recorded revenues of $7.9 million for the quarter,a marked improvement over the $3.2 million reported in the sameperiod last year. Income was also up sharply. Imatron recordednet income of $447,000, compared to a net loss of $2.7 millionin the second quarter of 1993.

Imatron shipped four Ultrafast CT scanners during the quarterand achieved several other milestones in its technology developmentprojects, according to president and CEO Lewis Meyer.

Imatron has a CT development agreement with Siemens, whichmarkets the Imatron scanner as Evolution EBT (electron-beam tomography).Imatron also operates HeartScan Imaging, which provides UltrafastCT coronary artery scanning in company-owned clinics (SCAN 4/6/94).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.